SCHEMBL30764733

SCHEMBL30764733

Cn1ccnc1CN1CC2(C1)CN(C(=O)Cc1ccc(F)cc1)C2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.46
POLB P06746 3/20 0.43
ME2 P23368 1/20 0.40
ME1 P48163 1/20 0.40
ME3 Q16798 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
ALDH1A1 P00352 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MAPT P10636 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KDM4E B2RXH2 2/20 0.37
MLNR O43193 1/20 0.37
CYP3A4 P08684 1/20 0.37
ARG1 P05089 1/20 0.37
ARG2 P78540 1/20 0.37
GHSR Q92847 2/20 0.37
MCHR1 Q99705 1/20 0.37
CHRM2 P08172 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30764731 0.76 HSD11B1 (0.56) HSD11B1POLBME2ME1ME3
SCHEMBL30764701 0.76 HSD11B1 (0.46) HSD11B1POLBME2ME1ME3
SCHEMBL30764737 0.74 HSD11B1 (0.46) HSD11B1POLBME2ME1ME3
SCHEMBL30764750 0.74 HSD11B1 (0.46) HSD11B1POLBME2ME1ME3
SCHEMBL30764722 0.73 HSD11B1 (0.46) HSD11B1POLBME2ME1ME3
SCHEMBL30764734 0.71 KMT2A (0.54) HSD11B1POLBMEN1KMT2AMCHR1
SCHEMBL30764706 0.71 L3MBTL1 (0.57) HSD11B1L3MBTL1ALDH1A1SMN1; SMN2MAPT
SCHEMBL30764704 0.71 KMT2A (0.54) HSD11B1POLBL3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL30764736 0.70 HSD11B1 (0.49) HSD11B1POLB
SCHEMBL30764709 0.69 HSD11B1 (0.53) HSD11B1POLBME2ME1ME3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568968-A1 (AZA)SPIROHEPTANE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS Remynd N.V. (BE) 2025-06-18 EP disclosed
WO-2024033479-A1 (AZA)SPIROHEPTANE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS REMYND N.V. (BE) 2024-02-15 WO disclosed